Join to View Full Profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-650-4344
Fax+1 603-727-7861
Dr. Ranjan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tulika Ranjan is a medical doctor specializing in Neurology, with a subspecialty in Neurooncology based in Pittsburgh, PA. She had her residency at Rutgers New Jersey Medical School and is a graduate from Sri Krishna Medical College. Her research interests are evident through her publications on the treatment of glioblastoma, which have been cited multiple times. She has also actively involved in clinical trials focusing on treating newly diagnosed and recurrent Glioblastoma. In 2013, she was recognized with the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation.
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Neurology, 2004 - 2008
Sri Krishna Medical College Class of 2002
Certifications & Licensure
CA State Medical License 2008 - Present
NH State Medical License 2024 - 2028
OH State Medical License 2026 - 2028
FL State Medical License 2021 - 2026
VT State Medical License 2024 - 2026
PA State Medical License 2015 - 2022
NC State Medical License 2012 - 2015
American Board of Psychiatry and Neurology Neurology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2014, 2017
Clinical Trials
- Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma Start of enrollment: 2018 May 20
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Start of enrollment: 2019 Jul 30
Publications & Presentations
PubMed
- Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study.Vivek Podder, Zouina Sarfraz, Tulika Ranjan, Andrea McCracken, Charlie Hurmiz
Scientific Reports. 2026-05-27 - Gaps in Diagnosis, Treatment, and Outcomes Among Patients with Brain Tumors in the United States: A State-of-the-Art Review.Vivek Podder, Zouina Sarfraz, Khalid Ahmad Qidwai, Arun Maharaj, Tulika Ranjan
Cancers. 2025-12-13 - Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis.Khalid Ahmad Qidwai, Zouina Sarfraz, Khalis Mustafayev, Lydia C Hodgson, Arun Maharaj
Cancers. 2025-11-29
Press Mentions
Dartmouth Cancer Center Taps Neuro-Oncology LeaderOctober 8th, 2025- Diagnosis for 1.30.22: Checking the Pulse of Florida Health Care News and PolicyJanuary 30th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
